Australia's largest stock trading and investment forum Australia's #1 stock forum

WFL

Click for more information

0.00%

0.3¢ wellfully limited

Performance Rights of 2014 - None achieved so far, page-227

First 227 Last

Share
Profile

Follow
happy Hippy

5,651 Posts.

45

14/10/16

06:19

Post #: 19850015
Share

Originally posted by Blackiwi ↑

Hi All.

If you cannot read between the lines, here it is:

- Blatant share grab by directors, based on what's about to unfold in near term - ie big news, potential large rerate.

- AGM pulled forwards by a month - first time in history - to allow time for material news to hit either prior AGM or just after, and time to enable OBJ to present to the institutions/Soph's prior the Christmas/EOY parties start.

- It is no secret that OBJ will be an Insto held commodity in the years that follow as the company transitions into revenue producing territory, as multiple products in the market become commercialised, with many new Multi-National Behemoths signing on over the next 15months and beyond.

-The mum and dad investors will drop off and the big boys will come to play.

- Why would OBJ wish to present to other parties before Christmas, when all that has happened since last roadshow has been the Olay Wave 1 launch, if there was no major new news? You wouldn't - unless there is something new worth shouting about.

- The same people everyone are flaming, are the very people whom have put us in the very position we are today - tight cash burn - multiple projects on the right pathways to commercialisation, 2 products already having been released into the market with powerhouse brands - with full rollouts of those products to come - lighthouse project in full swing [which is 5 years of innovative products, planned ahead for SK-11], Wave 1 through Wave 5 progressing, and a P&G relationship that is about to get bigger over the next period - bigger than everyone here b$@&#ing would care to realise.

- Has it taken longer than we all expected? Yes.

- Has the SP been frustratingly Painful? Yes.

- Has their been extensive opportunity and cash costs with little, or negative returns for most? Yes.

- Have there also been many people who have already made ALOT of money from OBJ from the ~1.6c days? Yes.

- Are many holders that invested, and not traded in the last two years of holding, seeing Red? Yes.

- Do I agree with the current share grab. No.

-Do I think there needs to be a performance milestone in order to secure these additional shares? Yes.

-Do I think that there's been enough moaning and complaining to directors to have this 10M share resolution changed? Yes.

-Do I think this Management team has the ability to progress the company further? Absolutely, unequivocally, yes.

- Do you think that there is a plethora of commercially sensitive progress that's OBJ has successfully implemented and achieved with numerous partners, but cannot be announced to the market just yet? Yes.

- Do I think we will see many Multi-Millionaires here in these threads due to their OBJ holdings within 12-18months. Absolutely.

- When should we expect to start seeing substantial revenues? 1st and 2nd quarters next year.

- Will we see BG commercialised? Yes.

- Will we see Advanced Packaging Commercialised. Yes.

- Will we see Surface commercialised? Yes.

- Will we see Pfizer signed on. Yes.

- Will we see DCE and Beauty Connect commercialised? Yes.

Patience required... Yes...More of it.

Kiwi.

————————
Note. The above are my personal thoughts, opinions and murmurings only. Does not constitute legal or investment advice whatsoever..

Expand

How are those 'multi-millions' looking now? As I suggested in last post the rush to the door has begun. 5 cents and below before months end IMO

OBJ Price at posting: 7.2¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

There are more pages in this discussion • 6 more messages in this thread...

First 227 Last

Add WFL (ASX) to my watchlist